IMBCR is an extremely professional, results-oriented research laboratory with an imperative to cure multiple myeloma. This is not just research for research's sake---they have their eye on the ball and are constantly advancing towards curative therapy. Helmed by Dr. Berenson, IMBCR is adjacent to his clinic where many patients are seen daily. This unique combination of a real-world practice, adjacent to a world-class research facility--has so many excited for the breakthroughs that have already sprung forth, and those that are imminent.
The Institute for Myeloma and Bone Cancer Research is a extremely helpful organization. Under the knowledgeable hand of Dr. James Berenson, the institute conducts ground-breaking research on new drugs and drug combinations, understanding the complex mechanisms involved in the myeloma progression and developing therapies that are tailored to the genetic profile of myeloma patients. Moreover, the institute has a large outreach function, producing informational videos and media interviews that relate important information to myeloma patients around the world. The Institute for Myeloma and Bone Cancer Research is a vital platform to help research and treat this difficult disease while improving the quality of life of myeloma patients everywhere.